Deregulated expression and activity of peripheral TLR6 in morbidly obese patients can mirror the liver inflammatory events that are well known drivers of obesity-related NASH pathogenesis. The gene discussed is TLR6; the disease is metabolic dysfunction-associated steatohepatitis.